Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Global RNAi for Therapeutic Sales Market Report 2016

  • QYR728205
  • 128 Pages
  • October 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of RNAi for Therapeutic

Revenue, means the sales value of RNAi for Therapeutic

This report studies sales (consumption) of RNAi for Therapeutic in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Alnylam Pharmaceuticals

Arbutus Biopharma (Tekmira)

Arrowhead Research

Dicerna Pharmaceuticals

Mirna Therapeutics

Quark Pharmaceuticals

RXi Pharmaceuticals

Silence Therapeutics

Benitec Biopharma

Miragen Therapeutics

Sylentis

Gradalis

Sirnaomics

Silenseed

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of RNAi for Therapeutic in these regions, from 2011 to 2021 (forecast), like

USA

China

Europe

Japan

India

Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

siRNA

miRNA

shRNA

Split by applications, this report focuses on sales, market share and growth rate of RNAi for Therapeutic in each application, can be divided into

Cancer

Cardiovascular

HBV

Table of Contents

Global RNAi for Therapeutic Sales Market Report 2016

1 RNAi for Therapeutic Overview

1.1 Product Overview and Scope of RNAi for Therapeutic

1.2 Classification of RNAi for Therapeutic

1.2.1 siRNA

1.2.2 miRNA

1.2.3 shRNA

1.3 Application of RNAi for Therapeutic

1.3.1 Cancer

1.3.2 Cardiovascular

1.3.3 HBV

1.4 RNAi for Therapeutic Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of RNAi for Therapeutic (2011-2021)

1.5.1 Global RNAi for Therapeutic Sales and Growth Rate (2011-2021)

1.5.2 Global RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

2 Global RNAi for Therapeutic Competition by Manufacturers, Type and Application

2.1 Global RNAi for Therapeutic Market Competition by Manufacturers

2.1.1 Global RNAi for Therapeutic Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global RNAi for Therapeutic Revenue and Share by Manufacturers (2011-2016)

2.2 Global RNAi for Therapeutic (Volume and Value) by Type

2.2.1 Global RNAi for Therapeutic Sales and Market Share by Type (2011-2016)

2.2.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)

2.3 Global RNAi for Therapeutic (Volume and Value) by Regions

2.3.1 Global RNAi for Therapeutic Sales and Market Share by Regions (2011-2016)

2.3.2 Global RNAi for Therapeutic Revenue and Market Share by Regions (2011-2016)

2.4 Global RNAi for Therapeutic (Volume) by Application

3 USA RNAi for Therapeutic (Volume, Value and Sales Price)

3.1 USA RNAi for Therapeutic Sales and Value (2011-2016)

3.1.1 USA RNAi for Therapeutic Sales and Growth Rate (2011-2016)

3.1.2 USA RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

3.1.3 USA RNAi for Therapeutic Sales Price Trend (2011-2016)

3.2 USA RNAi for Therapeutic Sales and Market Share by Manufacturers

3.3 USA RNAi for Therapeutic Sales and Market Share by Type

3.4 USA RNAi for Therapeutic Sales and Market Share by Application

4 China RNAi for Therapeutic (Volume, Value and Sales Price)

4.1 China RNAi for Therapeutic Sales and Value (2011-2016)

4.1.1 China RNAi for Therapeutic Sales and Growth Rate (2011-2016)

4.1.2 China RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

4.1.3 China RNAi for Therapeutic Sales Price Trend (2011-2016)

4.2 China RNAi for Therapeutic Sales and Market Share by Manufacturers

4.3 China RNAi for Therapeutic Sales and Market Share by Type

4.4 China RNAi for Therapeutic Sales and Market Share by Application

5 Europe RNAi for Therapeutic (Volume, Value and Sales Price)

5.1 Europe RNAi for Therapeutic Sales and Value (2011-2016)

5.1.1 Europe RNAi for Therapeutic Sales and Growth Rate (2011-2016)

5.1.2 Europe RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

5.1.3 Europe RNAi for Therapeutic Sales Price Trend (2011-2016)

5.2 Europe RNAi for Therapeutic Sales and Market Share by Manufacturers

5.3 Europe RNAi for Therapeutic Sales and Market Share by Type

5.4 Europe RNAi for Therapeutic Sales and Market Share by Application

6 Japan RNAi for Therapeutic (Volume, Value and Sales Price)

6.1 Japan RNAi for Therapeutic Sales and Value (2011-2016)

6.1.1 Japan RNAi for Therapeutic Sales and Growth Rate (2011-2016)

6.1.2 Japan RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

6.1.3 Japan RNAi for Therapeutic Sales Price Trend (2011-2016)

6.2 Japan RNAi for Therapeutic Sales and Market Share by Manufacturers

6.3 Japan RNAi for Therapeutic Sales and Market Share by Type

6.4 Japan RNAi for Therapeutic Sales and Market Share by Application

7 India RNAi for Therapeutic (Volume, Value and Sales Price)

7.1 India RNAi for Therapeutic Sales and Value (2011-2016)

7.1.1 India RNAi for Therapeutic Sales and Growth Rate (2011-2016)

7.1.2 India RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

7.1.3 India RNAi for Therapeutic Sales Price Trend (2011-2016)

7.2 India RNAi for Therapeutic Sales and Market Share by Manufacturers

7.3 India RNAi for Therapeutic Sales and Market Share by Type

7.4 India RNAi for Therapeutic Sales and Market Share by Application

8 Southeast Asia RNAi for Therapeutic (Volume, Value and Sales Price)

8.1 Southeast Asia RNAi for Therapeutic Sales and Value (2011-2016)

8.1.1 Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia RNAi for Therapeutic Sales Price Trend (2011-2016)

8.2 Southeast Asia RNAi for Therapeutic Sales and Market Share by Manufacturers

8.3 Southeast Asia RNAi for Therapeutic Sales and Market Share by Type

8.4 Southeast Asia RNAi for Therapeutic Sales and Market Share by Application

9 Global RNAi for Therapeutic Manufacturers Analysis

9.1 Alnylam Pharmaceuticals

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 RNAi for Therapeutic Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Arbutus Biopharma (Tekmira)

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 128 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Arrowhead Research

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 143 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 Dicerna Pharmaceuticals

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Oct Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Mirna Therapeutics

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Quark Pharmaceuticals

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 RXi Pharmaceuticals

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Medical Devices Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Silence Therapeutics

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Benitec Biopharma

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Miragen Therapeutics

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Sylentis

9.12 Gradalis

9.13 Sirnaomics

9.14 Silenseed

10 RNAi for Therapeutic Maufacturing Cost Analysis

10.1 RNAi for Therapeutic Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of RNAi for Therapeutic

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 RNAi for Therapeutic Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global RNAi for Therapeutic Market Forecast (2016-2021)

14.1 Global RNAi for Therapeutic Sales, Revenue Forecast (2016-2021)

14.2 Global RNAi for Therapeutic Sales Forecast by Regions (2016-2021)

14.3 Global RNAi for Therapeutic Sales Forecast by Type (2016-2021)

14.4 Global RNAi for Therapeutic Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List Of Tables and Figures

Figure Picture of RNAi for Therapeutic

Table Classification of RNAi for Therapeutic

Figure Global Sales Market Share of RNAi for Therapeutic by Type in 2015

Figure siRNA Picture

Figure miRNA Picture

Figure shRNA Picture

Table Applications of RNAi for Therapeutic

Figure Global Sales Market Share of RNAi for Therapeutic by Application in 2015

Figure Cancer Examples

Figure Cardiovascular Examples

Figure HBV Examples

Figure USA RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Figure China RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Figure Europe RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Figure Japan RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Figure India RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Figure Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Figure Global RNAi for Therapeutic Sales and Growth Rate (2011-2021)

Figure Global RNAi for Therapeutic Revenue and Growth Rate (2011-2021)

Table Global RNAi for Therapeutic Sales of Key Manufacturers (2011-2016)

Table Global RNAi for Therapeutic Sales Share by Manufacturers (2011-2016)

Figure 2015 RNAi for Therapeutic Sales Share by Manufacturers

Figure 2016 RNAi for Therapeutic Sales Share by Manufacturers

Table Global RNAi for Therapeutic Revenue by Manufacturers (2011-2016)

Table Global RNAi for Therapeutic Revenue Share by Manufacturers (2011-2016)

Table 2015 Global RNAi for Therapeutic Revenue Share by Manufacturers

Table 2016 Global RNAi for Therapeutic Revenue Share by Manufacturers

Table Global RNAi for Therapeutic Sales and Market Share by Type (2011-2016)

Table Global RNAi for Therapeutic Sales Share by Type (2011-2016)

Figure Sales Market Share of RNAi for Therapeutic by Type (2011-2016)

Figure Global RNAi for Therapeutic Sales Growth Rate by Type (2011-2016)

Table Global RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)

Table Global RNAi for Therapeutic Revenue Share by Type (2011-2016)

Figure Revenue Market Share of RNAi for Therapeutic by Type (2011-2016)

Figure Global RNAi for Therapeutic Revenue Growth Rate by Type (2011-2016)

Table Global RNAi for Therapeutic Sales and Market Share by Regions (2011-2016)

Table Global RNAi for Therapeutic Sales Share by Regions (2011-2016)

Figure Sales Market Share of RNAi for Therapeutic by Regions (2011-2016)

Figure Global RNAi for Therapeutic Sales Growth Rate by Regions (2011-2016)

Table Global RNAi for Therapeutic Revenue and Market Share by Regions (2011-2016)

Table Global RNAi for Therapeutic Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of RNAi for Therapeutic by Regions (2011-2016)

Figure Global RNAi for Therapeutic Revenue Growth Rate by Regions (2011-2016)

Table Global RNAi for Therapeutic Sales and Market Share by Application (2011-2016)

Table Global RNAi for Therapeutic Sales Share by Application (2011-2016)

Figure Sales Market Share of RNAi for Therapeutic by Application (2011-2016)

Figure Global RNAi for Therapeutic Sales Growth Rate by Application (2011-2016)

Figure USA RNAi for Therapeutic Sales and Growth Rate (2011-2016)

Figure USA RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

Figure USA RNAi for Therapeutic Sales Price Trend (2011-2016)

Table USA RNAi for Therapeutic Sales by Manufacturers (2011-2016)

Table USA RNAi for Therapeutic Market Share by Manufacturers (2011-2016)

Table USA RNAi for Therapeutic Sales by Type (2011-2016)

Table USA RNAi for Therapeutic Market Share by Type (2011-2016)

Table USA RNAi for Therapeutic Sales by Application (2011-2016)

Table USA RNAi for Therapeutic Market Share by Application (2011-2016)

Figure China RNAi for Therapeutic Sales and Growth Rate (2011-2016)

Figure China RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

Figure China RNAi for Therapeutic Sales Price Trend (2011-2016)

Table China RNAi for Therapeutic Sales by Manufacturers (2011-2016)

Table China RNAi for Therapeutic Market Share by Manufacturers (2011-2016)

Table China RNAi for Therapeutic Sales by Type (2011-2016)

Table China RNAi for Therapeutic Market Share by Type (2011-2016)

Table China RNAi for Therapeutic Sales by Application (2011-2016)

Table China RNAi for Therapeutic Market Share by Application (2011-2016)

Figure Europe RNAi for Therapeutic Sales and Growth Rate (2011-2016)

Figure Europe RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

Figure Europe RNAi for Therapeutic Sales Price Trend (2011-2016)

Table Europe RNAi for Therapeutic Sales by Manufacturers (2011-2016)

Table Europe RNAi for Therapeutic Market Share by Manufacturers (2011-2016)

Table Europe RNAi for Therapeutic Sales by Type (2011-2016)

Table Europe RNAi for Therapeutic Market Share by Type (2011-2016)

Table Europe RNAi for Therapeutic Sales by Application (2011-2016)

Table Europe RNAi for Therapeutic Market Share by Application (2011-2016)

Figure Japan RNAi for Therapeutic Sales and Growth Rate (2011-2016)

Figure Japan RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

Figure Japan RNAi for Therapeutic Sales Price Trend (2011-2016)

Table Japan RNAi for Therapeutic Sales by Manufacturers (2011-2016)

Table Japan RNAi for Therapeutic Market Share by Manufacturers (2011-2016)

Table Japan RNAi for Therapeutic Sales by Type (2011-2016)

Table Japan RNAi for Therapeutic Market Share by Type (2011-2016)

Table Japan RNAi for Therapeutic Sales by Application (2011-2016)

Table Japan RNAi for Therapeutic Market Share by Application (2011-2016)

Figure India RNAi for Therapeutic Sales and Growth Rate (2011-2016)

Figure India RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

Figure India RNAi for Therapeutic Sales Price Trend (2011-2016)

Table India RNAi for Therapeutic Sales by Manufacturers (2011-2016)

Table India RNAi for Therapeutic Market Share by Manufacturers (2011-2016)

Table India RNAi for Therapeutic Sales by Type (2011-2016)

Table India RNAi for Therapeutic Market Share by Type (2011-2016)

Table India RNAi for Therapeutic Sales by Application (2011-2016)

Table India RNAi for Therapeutic Market Share by Application (2011-2016)

Figure Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2011-2016)

Figure Southeast Asia RNAi for Therapeutic Revenue and Growth Rate (2011-2016)

Figure Southeast Asia RNAi for Therapeutic Sales Price Trend (2011-2016)

Table Southeast Asia RNAi for Therapeutic Sales by Manufacturers (2011-2016)

Table Southeast Asia RNAi for Therapeutic Market Share by Manufacturers (2011-2016)

Table Southeast Asia RNAi for Therapeutic Sales by Type (2011-2016)

Table Southeast Asia RNAi for Therapeutic Market Share by Type (2011-2016)

Table Southeast Asia RNAi for Therapeutic Sales by Application (2011-2016)

Table Southeast Asia RNAi for Therapeutic Market Share by Application (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alnylam Pharmaceuticals RNAi for Therapeutic Global Market Share (2011-2016)

Table Arbutus Biopharma (Tekmira) Basic Information List

Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Global Market Share (2011-2016)

Table Arrowhead Research Basic Information List

Table Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Arrowhead Research RNAi for Therapeutic Global Market Share (2011-2016)

Table Dicerna Pharmaceuticals Basic Information List

Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Dicerna Pharmaceuticals RNAi for Therapeutic Global Market Share (2011-2016)

Table Mirna Therapeutics Basic Information List

Table Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Mirna Therapeutics RNAi for Therapeutic Global Market Share (2011-2016)

Table Quark Pharmaceuticals Basic Information List

Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Quark Pharmaceuticals RNAi for Therapeutic Global Market Share (2011-2016)

Table RXi Pharmaceuticals Basic Information List

Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure RXi Pharmaceuticals RNAi for Therapeutic Global Market Share (2011-2016)

Table Silence Therapeutics Basic Information List

Table Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Silence Therapeutics RNAi for Therapeutic Global Market Share (2011-2016)

Table Benitec Biopharma Basic Information List

Table Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Benitec Biopharma RNAi for Therapeutic Global Market Share (2011-2016)

Table Miragen Therapeutics Basic Information List

Table Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Miragen Therapeutics RNAi for Therapeutic Global Market Share (2011-2016)

Table Sylentis Basic Information List

Table Sylentis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sylentis RNAi for Therapeutic Global Market Share (2011-2016)

Table Gradalis Basic Information List

Table Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Gradalis RNAi for Therapeutic Global Market Share (2011-2016)

Table Sirnaomics Basic Information List

Table Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sirnaomics RNAi for Therapeutic Global Market Share (2011-2016)

Table Silenseed Basic Information List

Table Silenseed RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Silenseed RNAi for Therapeutic Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of RNAi for Therapeutic

Figure Manufacturing Process Analysis of RNAi for Therapeutic

Figure RNAi for Therapeutic Industrial Chain Analysis

Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015

Table Major Buyers of RNAi for Therapeutic

Table Distributors/Traders List

Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast (2016-2021)

Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)

Table Global RNAi for Therapeutic Sales Forecast by Regions (2016-2021)

Table Global RNAi for Therapeutic Sales Forecast by Type (2016-2021)

Table Global RNAi for Therapeutic Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370